| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.2 |